Gabriel Douville

Investment Analyst



Gabriel Douville - Investment Analyst at OneVentures, leading Australian Venture Capital firm


Gabriel joins OneVentures after having completed his MBA at the Australian Graduate School of Management, UNSW. Before moving to Australia, Gabriel worked as a Specialty Sales Representative for both Shire Pharmaceuticals and Paladin Laboratories in Montreal, in areas ranging from allergy immunotherapy, antibiotics and psychiatry, more specifically sleep disorders and adult attention deficit disorder.

During his MBA, he interned as a consultant at Westpac, Faethm and Opus Medical, on fintech, artificial intelligence and medical device market-entry projects, respectively. More recently he was the Program Manager at Cicada Innovations for their NSW Health-sponsored Medical Device Commercialisation Training Program (MDCTP), which over the course of 3 years has led to the creation of 11 medtech companies raising a total of $24.7M in funding.

Gabriel holds a BSc degree with a major in Biology from McGill University and an MSc from Université Laval where he published work on personalised medicine for assisted reproductive technologies. He’s an avid cyclist and basketball fan.


Sydney, AU